Ribomic (TSE:4591) Other Current Liabilities: 円41.87 Mil (As of Mar. 2026)


TSE:4591 Ribomic Inc TSE:4591
30 GF Score
Price 円66.00
! 3 Warning Signs
View Full Analysis

What is Ribomic Other Current Liabilities?

Ribomic TSE:4591 +3.13% 30 Other Current Liabilities is 円41.87 Mil as of Mar. 2026. GuruFocus rates TSE:4591 with a GF Score™ of 30/100. The stock has 3 warning signs investors should review.

Ribomic's other current liabilities for the quarter that ended in Mar. 2026 was 円41.87 Mil.

Ribomic's quarterly other current liabilities increased from Mar. 2025 (円32.50 Mil) to Sep. 2025 (円58.16 Mil) but then declined from Sep. 2025 (円58.16 Mil) to Mar. 2026 (円41.87 Mil).

Ribomic's annual other current liabilities declined from Mar. 2024 (円57.78 Mil) to Mar. 2025 (円32.50 Mil) but then increased from Mar. 2025 (円32.50 Mil) to Mar. 2026 (円41.87 Mil).

Ribomic Other Current Liabilities Related Terms

Ribomic Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Ribomic's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ribomic Other Current Liabilities Chart

Ribomic Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 47.89 44.09 57.78 32.50 41.87

Ribomic Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 57.78 23.15 32.50 58.16 41.87
TSE:4591
30GF Score
Ribomic Inc TSE:4591
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ribomic Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of 円41.87 Mil mean?
Ribomic (TSE:4591) has a Other Current Liabilities of 円41.87 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Ribomic.
Is Ribomic's Other Current Liabilities too high?
Ribomic's current Other Current Liabilities is 円41.87 Mil. Overall, Ribomic has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Ribomic's Other Current Liabilities compare to VRTX and REGN?
Ribomic's Other Current Liabilities of 円41.87 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Ribomic. Ribomic's current Other Current Liabilities is 円41.87 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ribomic stock overvalued right now?
Ribomic (TSE:4591) has a current Other Current Liabilities of 円41.87 Mil. The current Other Current Liabilities is 円41.87 Mil. Ribomic's overall GF Score™ is 30/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Ribomic (TSE:4591), the current Other Current Liabilities is 円41.87 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ribomic Business Description

Address 3-16-13 Usui Building, Shirokanedai, Minato-ku, Tokyo, JPN, 108-0071
Ribomic Inc is a biopharmaceutical venture company based in Tokyo. The company is developing molecular targeted pharmaceutical drugs using RNA aptamers with its unique and advanced platform technologies, the RiboART System.
30GF Score

Get the complete analysis for TSE:4591

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円66.00
Price